1. United States of America Stocks

  2. •

    Industrials

  3. •

    Specialty Business Services
ADARx Pharmaceuticals, Inc.

ADARx Pharmaceuticals, Inc.

ADRX
ADARx Pharmaceuticals, Inc.US flagNASDAQ
18.25
USD
-1.29
- -
1.87BMarket Cap
2024 Y
2025 Y
Revenue per Share
- -
0.05
Basic EPS, GAAP
-0.62
-0.97
Free Cash Flow per Basic Share
-0.65
3.44
Dividend per Share
- -
- -
Book Value per Share
-1.34
-1.98
Tangible Book Value per Share
-1.34
-1.98
Basic Weighted Avg Shares
75
75
Sales/Revenue/Turnover
- -
3
Operating Margin (%)
- -
-2,562.05
Depreciation Expense
2
2
Net Income, GAAP
-46
-73
Effective Tax Rate (%)
- -
- -
Profit Margin (%)
- -
-2,119.11
Working Capital
217
463
LT Debt
4
6
Total Equity
-137
-202
Return on Invested Capital (%)
- -
- -
Return on Capital (%)
- -
- -
Return on Common Equity (%)
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
47.48%
Free Cash Flow
- -
- -
-629.1%
Net Income, GAAP
- -
- -
57.65%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
3
2026
2
1
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-0.62
2025
-0.21
- -
- -
- -
-0.97
2026
-0.22
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Zhen Li
Sector
Industrials
Industry
Specialty Business Services
Address
5871 Oberlin Drive, Suite 200 San Diego CA United States of America 92121
IPO Date
Sep 25, 2026
CIK
0001802369
Website
adarx.com
Similar Companies
Water Intelligence plc (WATR.L)
GL Events S.A. (GLCDF)
Maximus, Inc. (MMS)
Max Sight Group Holdings Limited (8483.HK)
IVE Group Limited (IGL.AX)
Global Kids Company Corp. (6189.T)
Business
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.

Company News

Company News APIChatGPT

  • globenewswire.com

    ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares Granted in Its Initial Public Offering

  • gurufocus.com

    First Look: Disney Layoffs, Apple Smart Home Launch, Goldman CEO Talks

  • reuters.com

    ADARx Pharmaceuticals raises $446.3 million in upsized US IPO

  • globenewswire.com

    ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering